BASF converts to hand sanitizer production at New Jersey, Michigan facilities
Neither site regularly produces hand sanitizer, but BASF scientists and engineers worked on compressed timelines to develop the product to help meet the increased demands needed to combat COVID-19.
BASF Corp., the North American affiliate of German chemical maker BASF SE, has begun producing hand sanitizer from two of its plants in the U.S. to help meet the increased demands needed to safely combat the COVID-19 pandemic.
The company is providing the states of New Jersey and New York with hand sanitizer manufactured at its facility in Washington, N.J. free of charge. BASF said that it does not regularly produce hand sanitizer at its New Jersey location, but a team of BASF scientists and engineers worked on a compressed timeline to develop a safe and high-quality product.
The New Jersey plant is the first BASF location in the U.S. to supply hand sanitizer. The facility will produce approximately 3,500 gallons of hand sanitizer to be distributed to health care systems and government agencies in New Jersey and New York, and other BASF locations in the U.S.
And the BASF Corp. site in Wyandotte, Mich. has created and produced a hand sanitizer, HandClasp, with the first 1,000 gallons in the U.S. donated to the Henry Ford Health System.
The Wyandotte facility is home to one of BASF’s largest research and development centres and manufacturing sites in North America with more than 1,200 employees. As at the Washington, N.J. site, BASF does not regularly produce hand sanitizer at the Wyandotte location, however the facility received authorization from the U.S. Food and Drug Administration to temporarily produce a safe and high-quality sanitizing product. The facility has produced over 8,000 gallons of hand sanitizer being distributed to the Henry Ford Health System, and other health care systems in Michigan, Texas, Louisiana, Mexico and Canada, as well as other BASF locations in the U.S.